A drug typically used for a rare disorder could extend the lives of patients battling a form of ovarian cancer, a study has ...
A well-known diabetes drug may have a previously overlooked effect on the body’s metabolism.
You know the expression, “If you want to get something done, ask a working mother?” Surprising as it may seem, the same holds ...
Young cancer patients with private insurance survive longer due to better access to care and treatment. Coverage instability worsens outcomes, but policy changes could help.
A prostate cancer patient from Worthing has become the first in Sussex to receive an innovative new treatment. Darius Aibara, ...
Hope and positive mental attitude are most durable when conceptualized as meaning-making alongside uncertainty, not magical ...
Fighting cancer can be an isolating experience. But one Valley organization is working to make sure no one has to go through ...
On average, patients with platinum-resistant ovarian cancer only live for around one year to 18 months after diagnosis.
Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival.
Breana LeBouef is helping Bayou Region cancer patients find support, strength and a path forward—one step at a time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results